Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 15,035,000 | 14,487,000 | 13,830,000 | 14,959,000 | 14,593,000 |
| Cost of Goods | 4,024,000 | 3,926,000 | 3,881,000 | 3,934,000 | 4,216,000 |
| Gross Profit | 11,011,000 | 10,561,000 | 9,949,000 | 11,025,000 | 10,377,000 |
| Operating Expenses | 16,023,000 | 6,755,000 | 6,462,000 | 6,919,000 | 5,310,000 |
| Operating Income | -5,012,000 | 3,806,000 | 3,487,000 | 4,106,000 | 5,067,000 |
| Other Income | -323,000 | -156,000 | 26,000 | -523,000 | -580,000 |
| Pre-tax Income | -5,335,000 | 3,650,000 | 3,513,000 | 3,583,000 | 4,487,000 |
| Income Tax | 637,000 | 825,000 | 496,000 | 330,000 | 538,000 |
| Net Income Continuous | -5,972,000 | 2,825,000 | 3,017,000 | 3,253,000 | 3,949,000 |
| Minority Interests | 3,000 | 4,000 | N/A | 5,000 | 5,000 |
| Net Income | $-5,975,000 | $2,821,000 | $3,017,000 | $3,248,000 | $3,944,000 |
| EPS Basic Total Ops | -2.35 | 1.11 | 1.19 | 1.28 | 1.56 |
| EPS Basic Continuous Ops | -2.35 | 1.11 | 1.18 | 1.28 | 1.56 |
| EPS Diluted Total Ops | -2.35 | 1.11 | 1.18 | 1.28 | 1.55 |
| EPS Diluted Continuous Ops | -2.35 | 1.11 | 1.18 | 1.28 | 1.55 |
| EPS Diluted Before Non-Recurring Items | -2.06 | 1.40 | 1.62 | N/A | N/A |
| EBITDA(a) | $-4,109,000 | $4,797,000 | $4,379,000 | $5,065,000 | $6,005,000 |